SG11201810082VA - Methods and compositions for treating advanced stage non-small cell lung cancer - Google Patents
Methods and compositions for treating advanced stage non-small cell lung cancerInfo
- Publication number
- SG11201810082VA SG11201810082VA SG11201810082VA SG11201810082VA SG11201810082VA SG 11201810082V A SG11201810082V A SG 11201810082VA SG 11201810082V A SG11201810082V A SG 11201810082VA SG 11201810082V A SG11201810082V A SG 11201810082VA SG 11201810082V A SG11201810082V A SG 11201810082VA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- jheng
- danshuei
- jhong
- sec
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 208000002154 non-small cell lung carcinoma Diseases 0.000 title abstract 3
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 title abstract 3
- FWFSEYBSWVRWGL-UHFFFAOYSA-N cyclohex-2-enone Chemical class O=C1CCCC=C1 FWFSEYBSWVRWGL-UHFFFAOYSA-N 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 11111111111111111111111111111111111111111111111111111111111111111111111111111111 Organization 0 International Bureau (10) International Publication Number (43) International Publication Date .....0\"\" WO 2017/197370 Al 16 November 2017 (16.11.2017) WIPO I PCT (51) International Patent Classification: A61K 31/575 (2006.01) A61K 31/122 (2006.01) (21) International Application Number: PCT/US2017/032562 (22) International Filing Date: 12 May 2017 (12.05.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/336,388 13 May 2016 (13.05.2016) US (71) Applicant: GOLDEN BIOTECHNOLOGY CORPO- RATION [US/US]; 101 Hutson Street, Suite 2100, Jersey City, CA 07302 (US). (72) Inventors: LIU, Sheng-Yung; 15F, No. 27-6, Sec. 2, Jhong-Jheng E, Rd., Danshuei, New Taipei City, 251 (TW). _ CHEN, Chih-Ming; 15F, No. 27-6, Sec. 2, Jhong-Jheng E, Rd., Danshuei, New Taipei City, 251 (TW). CHEN, Pei-Ni; 15F, No. 27-6, Sec. 2, Jhong-Jheng E, Rd., Danshuei, New — Taipei City, 251 (TW). CHENG, Hao-Yu; 15F, No. 27-6, Sec. 2, Jhong-Jheng E, Rd., Danshuei, New Taipei City, 251 = (TW). = Agent: LIANG, Chang-Hsing et al.; 12707 High Bluff (74) = = Drive, Suite 200, San Diego, CA 92130 (US). Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. = (81) _ = = — = = — = Designated States (unless otherwise indicated, for every = (84) = kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). = — = — 1-1 0 N Published: IN en — with international search report (Art. 21(3)) 0\ Il IN 1-1 (54) Title: METHODS AND COMPOSITIONS FOR TREATING ADVANCED STAGE NON-SMALL CELL LUNG CANCER © ei (57) : The present invention provides methods and compositions for treating advanced stage non-small cell lung cancer by 0 cyclohexenone compounds.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662336388P | 2016-05-13 | 2016-05-13 | |
| PCT/US2017/032562 WO2017197370A1 (en) | 2016-05-13 | 2017-05-12 | Methods and compositions for treating advanced stage non-small cell lung cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201810082VA true SG11201810082VA (en) | 2018-12-28 |
Family
ID=60266857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201810082VA SG11201810082VA (en) | 2016-05-13 | 2017-05-12 | Methods and compositions for treating advanced stage non-small cell lung cancer |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11786485B2 (en) |
| EP (1) | EP3454866A4 (en) |
| JP (2) | JP2019514986A (en) |
| KR (1) | KR102359784B1 (en) |
| CN (2) | CN109195606A (en) |
| AU (1) | AU2017261826B2 (en) |
| CA (1) | CA3023768A1 (en) |
| MY (1) | MY194948A (en) |
| SG (1) | SG11201810082VA (en) |
| TW (1) | TWI803463B (en) |
| WO (1) | WO2017197370A1 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8309611B2 (en) * | 2010-09-20 | 2012-11-13 | Golden Biotechnology Corporation | Methods and compositions for treating lung cancer |
| TWI597061B (en) * | 2013-02-20 | 2017-09-01 | 國鼎生物科技股份有限公司 | Methods and compositions for treating leukemia |
| US20140274979A1 (en) * | 2013-03-13 | 2014-09-18 | Golden Biotechnology Corporation | Method for the treatment of fatty liver disease |
| WO2014151304A1 (en) * | 2013-03-15 | 2014-09-25 | Golden Biotechnology Corporation | Therapeutic methods and compositions utilizing cyclohexenone compounds |
-
2017
- 2017-05-12 TW TW106115899A patent/TWI803463B/en active
- 2017-05-12 CN CN201780028718.3A patent/CN109195606A/en active Pending
- 2017-05-12 AU AU2017261826A patent/AU2017261826B2/en active Active
- 2017-05-12 CN CN202311355907.5A patent/CN117379405A/en active Pending
- 2017-05-12 WO PCT/US2017/032562 patent/WO2017197370A1/en unknown
- 2017-05-12 US US16/300,552 patent/US11786485B2/en active Active
- 2017-05-12 CA CA3023768A patent/CA3023768A1/en active Pending
- 2017-05-12 SG SG11201810082VA patent/SG11201810082VA/en unknown
- 2017-05-12 KR KR1020187036078A patent/KR102359784B1/en active IP Right Grant
- 2017-05-12 JP JP2018558383A patent/JP2019514986A/en active Pending
- 2017-05-12 MY MYPI2018001904A patent/MY194948A/en unknown
- 2017-05-12 EP EP17797009.2A patent/EP3454866A4/en active Pending
-
2022
- 2022-09-30 JP JP2022158674A patent/JP2023012458A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3454866A4 (en) | 2020-01-08 |
| AU2017261826B2 (en) | 2022-09-29 |
| EP3454866A1 (en) | 2019-03-20 |
| CN117379405A (en) | 2024-01-12 |
| MY194948A (en) | 2022-12-28 |
| KR20190008315A (en) | 2019-01-23 |
| KR102359784B1 (en) | 2022-02-09 |
| JP2019514986A (en) | 2019-06-06 |
| CN109195606A (en) | 2019-01-11 |
| WO2017197370A1 (en) | 2017-11-16 |
| TWI803463B (en) | 2023-06-01 |
| AU2017261826A1 (en) | 2018-11-29 |
| CA3023768A1 (en) | 2017-11-16 |
| US20190209492A1 (en) | 2019-07-11 |
| TW201742623A (en) | 2017-12-16 |
| JP2023012458A (en) | 2023-01-25 |
| US11786485B2 (en) | 2023-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201808990QA (en) | Compositions for topical application of compounds | |
| SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201805044WA (en) | Compounds useful as kinase inhibitors | |
| SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
| SG11201809559UA (en) | Substituted pyridines as inhibitors of dnmt1 | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201810983PA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
| SG11201804901WA (en) | Compounds for the treatment of cancer and inflammatory disease | |
| SG11201804915RA (en) | Methods for treating huntington's disease | |
| SG11201807784SA (en) | 3-desoxy derivative and pharmaceutical compositions thereof | |
| SG11201808125RA (en) | Methods for solid tumor treatment | |
| SG11201810525XA (en) | Anti-gitr antibodies and uses thereof | |
| SG11201808713YA (en) | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier | |
| SG11201809499UA (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
| SG11201904535VA (en) | Prevention and treatment of bone and cartilage damage or disease | |
| SG11201810333UA (en) | Combination of anti-cd20 antibody, p13 kinase-delta selective inhibitor, and btk inhibitor to treat b-cell proliferative disorders | |
| SG11201804704PA (en) | Compositions and methods for decreasing tau expression | |
| SG11201805001UA (en) | Method of treating influenza a | |
| SG11201810965YA (en) | 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors | |
| SG11201808762XA (en) | Diagnostic methods for patient specific therapeutic decision making in cancer care | |
| SG11201808525UA (en) | Anti-complement factor bb antibodies and uses thereof | |
| SG11201909837YA (en) | Methods for treating lung disorders | |
| SG11201805204WA (en) | Nicotine particle capsule | |
| SG11201809882XA (en) | Pharmaceutical combinations for treating cancer |